Furthermore, increases in migration and invasiveness of cancer cells demonstrating high expression of ANKHD1 has also been described in hepatocellular carcinoma [61], breast cancer [38], non-small-cell lung cancer [53] and multiple myeloma [57] cells. Here, ANKHD1 is linked to plasma cell myeloma.